A Retrospective Evaluation of Eribulin Dosing Schedules in Metastatic Breast Cancer
Class of 2016 Abstract === Objectives: To determine the number of patients treated with eribulin who required an alternate dosing schedule other than “day 1/day 8” due to side effects. Methods: Chart reviews were conducted on all patients who met inclusion criteria. Data collected included patient...
Main Authors: | , , |
---|---|
Language: | en_US |
Published: |
The University of Arizona.
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/613986 http://arizona.openrepository.com/arizona/handle/10150/613986 |